Akari Therapeutics Plc of TAMPA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-30. The offering totals $12.5M, of which $12.5M was reported sold. Industry: Biotechnology.
Showing 25 of 52 people.
| Name | Role | Location |
|---|---|---|
| Robert Doman | Director | Philadelphia, PA |
| Amos Eiran | Director | Herzeliya, L3 |
| Johnson Lau | Director | Xi'an, F4 |
| Fredric Price | Director | New Haven, CT |
| David Sidransky | Director | Germantown, MD |
| Saul Yedgar | Director | Jerusalem, L3 |
| Alan Harris | Executive Officer | New York, NY |
| Saul Yedgar | Executive Officer | Jerusalem, L3 |
| James Hill | Director | Aurora, CO |
| Dov Elefant | Director | Suwanee, GA |
| Dov Elefant | Executive Officer | Suwanee, GA |
| Samir Patel | Director | TAMPA, FL |
| Samir Patel | Related Person | TAMPA, FL |
| Sandip Patel | Director | TAMPA, FL |
| Sandip Patel | Related Person | TAMPA, FL |
| Ray Prudo | Director | TAMPA, FL |
| Ray Prudo | Executive Officer | TAMPA, FL |
| Ray Prudo | Related Person | TAMPA, FL |
| Hoyoung Huh | Director | TAMPA, FL |
| Hoyoung Huh | Related Person | TAMPA, FL |
| Kameel Farag | Executive Officer | TAMPA, FL |
| Kameel Farag | Related Person | TAMPA, FL |
| Rob Bazemore | Director | TAMPA, FL |
| Rob Bazemore | Related Person | TAMPA, FL |
| Abizer Gaslightwala | Director | TAMPA, FL |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2026-06-03 | D | $5.5M | $1.8M |
| 2025-10-24 | D | $6.3M | $6.3M |
| 2024-01-09 | D | $2.0M | $2.0M |
| 2023-10-19 | D | $2.0M | $2.0M |
| 2022-09-27 | D | $12.8M | $12.8M |
| 2021-07-22 | D | $12.3M | $12.3M |
| 2020-03-11 | D | $9.6M | $9.6M |
| 2019-07-12 | D | $4.5M | $4.5M |
| 2015-09-28 | D | $75.0M | $75.0M |
| 2013-02-01 | D | $10.0M | $931K |
| 2012-12-13 | D/A | $1.5M | $1.5M |
| 2012-12-12 | D | $1.5M | $1.5M |
| 2012-04-13 | D | $1.1M | — |